Oncological
At the cellular level, photobiomodulation (PBM) and photodynamic therapy (PDT) play a crucial role in addressing oncological issues.
Specific dose programming enables reproducible results in individuals with diverse morphologies by use of our precision optical dosimeters, adjusting the optical dose for each condition to achieve the optimal scheme of cellular stimulation, inhibition, or destruction.
Biophotonic-based medicine contributes to cancer resolution throughout the four stages of disease progression.
The technique allows light to enter the body, achieving a complex tissue-scattering effect according to radiative transfer equations.
With advanced light injection techniques, biophotonic-based treatments trigger potent biological responses to inhibit, destroy, or stimulate cells that have undergone harmful mutations within the body.
Said mutation may be due to genetic factors, external carcinogens, or abnormal cell behavior, leading to the loss of growth regulation.
Affected cells can easily infiltrate surrounding tissues, spreading to other body regions through the bloodstream or lymphatic system.
This process creates a chain reaction that favors malignant cell proliferation, exacerbating the issue.
In oncological applications, photobiomodulation (PBM) is complemented with photodynamic therapy (PDT) to activate photosensitive substances exclusively in the irradiation zone.
In contrast, biophotonics-based treatments, by intelligently injecting light into the body with specific optical doses and high-precision technology, limits the impact on affected cells, localizing the region of action until the desired result is achieved.